The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium (Q38793676)
Jump to navigation
Jump to search
scientific article published on 10 May 2017
- TheBRCA1c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
Language | Label | Description | Also known as |
---|---|---|---|
English | The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium |
scientific article published on 10 May 2017 |
|
Statements
1 reference
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium (English)
1 reference
Barbara Wappenschmidt
1 reference
Fergus Couch
1 reference
Norbert Arnold
1 reference
Bent Ejlertsen
1 reference
Amanda Ewart Toland
1 reference
Amanda B Spurdle
1 reference
David E Goldgar
1 reference
Marinus J Blok
1 reference
Ans Mw van den Ouweland
1 reference
Torben A Kruse
1 reference
Huong D Meeks
1 reference
Margriet J Collée
1 reference
Maaike Pg Vreeswijk
1 reference
Mads Thomassen
1 reference
Ã…ke Borg
1 reference
Thomas Van Overeem Hansen
1 reference
Emily J Hallberg
1 reference
Setareh Moghadasi
1 reference
Linda Am Janssen
1 reference
Muriel A Adank
1 reference
Jan C Oosterwijk
1 reference
Ylva Paulsson-Karlsson
1 reference
Andrea Gehrig
1 reference
Inge Søkilde Pedersen
1 reference
Erik Teugels
1 reference
Nicolas Janin
1 reference
Kathy Tucker
1 reference
Valeria Viassolo
1 reference
Christie J Van Asperen
1 reference
Encarna Gómez GarcÃa
1 reference
10 May 2017
1 reference
1 reference
Identifiers
1 reference
1 reference